NeoGenomics Launches New Sequencing Assay for Rapid Genetic Profiling of AML
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read More
Search Results for: leukemia
New Panel-Agnostic Automated AML Diagnosis Solution Unveiled
A new diagnostic classification module for AHEAD Medicine’s Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Read More
Whole Genome Sequencing Improves Pediatric Cancer Care
Whole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read More
Qlucore Insights Can Classify Primary Lung Samples, Metastatic Lesions
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read More
OGT Launches New Panel for Myeloid Cancer
OGT launched a new next-generation sequencing (NGS) tool designed to identify key fusion genes associated with acute myeloid leukemia (AML).
Read More